Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1077.6000 -7.40 (-0.68%)

NSE Dec 29, 2025 11:18 AM

New 52W High in past week

Volume: 669.4K

Laurus Labs Ltd.

25 Jan 2024

1077.60

-0.68%

Laurus Labs (SELL): Challenges galore cut to SELL

Sell: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Fourth straight quarterly miss with upsets on all fronts; Q3 revenue/ EBITDA well short of Bloomberg consensus by 13%/79%

Number of FII/FPI investors increased from 293 to 340 in Sep 2025 qtr.